Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01011634 · ClinicalTrials.gov registry record · Phase 4
Trial Comparing Intravenous and Oral Moderate Sedation for First Trimester Surgical Abortions
A Phase 4 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT01011634 is a Phase 4 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 18 participants.
The verdict
NCT01011634, a Phase 4 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
In the United States, the majority of first-trimester surgical abortions are performed in outpatient clinics that utilize a wide variety of oral and intravenous regimens for pain control. The specific aim of this study is to evaluate the equivalency of intravenous moderate sedation (fentanyl 100 mcg and midazolam 2 mg) versus oral analgesia/anxiolysis (lorazepam 2 mg sublingual, hydrocodone/acetaminophen 5/500 mg, and ibuprofen 800 mg) for first-trimester surgical abortions. The investigators hypothesize that oral moderate sedation and intravenous moderate sedation will be equivalent in controlling pain as measured by a difference of +/- 10 on a 100-point (range 0-100) visual analog pain scale.
Interventions
- DRUG Intravenous moderate sedation versus oral medication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01011634
The ClinicalTrials.gov registry entry for NCT01011634 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravenous moderate sedation versus oral medication is the first listed.
NCT01011634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01011634 about?
NCT01011634 is a clinical study titled "Trial Comparing Intravenous and Oral Moderate Sedation for First Trimester Surgical Abortions". In the United States, the majority of first-trimester surgical abortions are performed in outpatient clinics that utilize a wide variety of oral and intravenous regimens for pain control. The specific aim of this study is to evaluate the equivalency of intravenous moderate sedation (fentanyl 100 mcg...
What is the current status of trial NCT01011634?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2007-05. Estimated completion is 2008-11.
What interventions are being tested in trial NCT01011634?
The interventions under investigation include: Intravenous moderate sedation versus oral medication (DRUG).
Who is sponsoring clinical trial NCT01011634?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.